- Home
- AMS vs TENX Comparison
AMS vs TENX Comparison
Compare AMS & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMS
- TENX
- Stock Information
- Founded
- AMS 1980
- TENX 1967
- Country
- AMS United States
- TENX United States
- Employees
- AMS N/A
- TENX 6
- Industry
- AMS Medical Specialities
- TENX Biotechnology: Pharmaceutical Preparations
- Sector
- AMS Health Care
- TENX Health Care
- Exchange
- AMS Nasdaq
- TENX Nasdaq
- Market Cap
- AMS 19.3M
- TENX 21.6M
- IPO Year
- AMS N/A
- TENX N/A
- Fundamental
- Price
- AMS $2.73
- TENX $5.53
- Analyst Decision
- AMS
- TENX Strong Buy
- Analyst Count
- AMS 0
- TENX 3
- Target Price
- AMS N/A
- TENX $16.00
- AVG Volume (30 Days)
- AMS 17.4K
- TENX 18.4K
- Earning Date
- AMS 04-04-2025
- TENX 05-13-2025
- Dividend Yield
- AMS N/A
- TENX N/A
- EPS Growth
- AMS 243.96
- TENX N/A
- EPS
- AMS 0.33
- TENX N/A
- Revenue
- AMS $28,340,000.00
- TENX N/A
- Revenue This Year
- AMS $13.15
- TENX N/A
- Revenue Next Year
- AMS N/A
- TENX N/A
- P/E Ratio
- AMS $8.12
- TENX N/A
- Revenue Growth
- AMS 32.90
- TENX N/A
- 52 Week Low
- AMS $2.51
- TENX $2.77
- 52 Week High
- AMS $4.60
- TENX $7.89
- Technical
- Relative Strength Index (RSI)
- AMS 49.69
- TENX 42.57
- Support Level
- AMS $2.62
- TENX $4.63
- Resistance Level
- AMS $2.77
- TENX $5.75
- Average True Range (ATR)
- AMS 0.15
- TENX 0.42
- MACD
- AMS -0.00
- TENX -0.04
- Stochastic Oscillator
- AMS 53.06
- TENX 47.70
About AMS American Shared Hospital Services
American Shared Hospital Services provides stereotactic radiosurgery equipment, Advanced radiation therapy and related equipment. It currently provides Gamma Knife units to medical centers and stand-alone facilities. The company, along with its subsidiaries, operates through the following operations: Gamma Knife, Advanced Radiation Therapy Equipment and Services, and Proton Beam Radiation Therapy Operations. It generates most of its revenue from the domestic market.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.